FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

François Goldwasser

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Johann Dréanic; François Goldwasser; Olivier Mir; Géraldine Perkins; Pascaline Boudou-Rouquette; Catherine Brezault; Romain Coriat; Marion Dhooge; Stanislas Chaussade
Cervical extravasation of bevacizumab.
O Huillard; Olivier Mir; M Peyromaure; Stanislas Ropert; C Tlemsani; M Zerbib; P Boudou-Rouquette; N Barry Delongchamps; J Giroux; François Goldwasser
Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients.
Marion Dhooge; François Goldwasser; Olivier Mir; Géraldine Perkins; Pascaline Boudou-Rouquette; Catherine Brezault; Romain Coriat; Stanislas Chaussade
Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of François Goldwasser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Johann Dréanic; François Goldwasser; Olivier Mir; Géraldine Perkins; Pascaline Boudou-Rouquette; Catherine Brezault; Romain Coriat; Marion Dhooge; Stanislas Chaussade
Cervical extravasation of bevacizumab.
Anti-cancer drugs 2013;24(4):426-8.
2013: O Huillard; Olivier Mir; M Peyromaure; Stanislas Ropert; C Tlemsani; M Zerbib; P Boudou-Rouquette; N Barry Delongchamps; J Giroux; François Goldwasser
Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients.
British journal of cancer 2013;108(5):1034-41.
2013: Marion Dhooge; François Goldwasser; Olivier Mir; Géraldine Perkins; Pascaline Boudou-Rouquette; Catherine Brezault; Romain Coriat; Stanislas Chaussade
Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis.
Oncology 2013;84(1):32-8.
2012: Audrey Thomas-Schoemann; Bernard Weill; Maxime Annereau; Frédéric Batteux; Christiane Chéreau; Alain Dauphin; François Goldwasser; François LEMARE; Céline Mongaret; Carole Nicco; Jérôme Alexandre
Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(11):5171-7.
2012: Olivier Mir; Stanislas Pol; Stanislas Ropert; Philippe Sogni; Pascaline Boudou-Rouquette; Anatole Cessot; Stanislas Chaussade; Romain Coriat; Jean-Philippe Durand; Vincent Mallet; François Goldwasser
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib.
Medical oncology (Northwood, London, England) 2012;29(4):2793-9.
2012: Jennifer Arrondeau; Benoit Blanchet; Pascaline Boudou-Rouquette; Romain Coriat; Guillaume Dumas; Olivier Mir; Manuel J Rodrigues; Stanislas Ropert; Benoit Rousseau; François Goldwasser
Sorafenib exposure decreases over time in patients with hepatocellular carcinoma.
Investigational new drugs 2012;30(5):2046-9.
2012: Marilyne Hornecker; Olivier Mir; Stanislas Ropert; Hind Sassi; Fabrice Taieb; Halim Abbas; Bertrand Billemont; Benoit Blanchet; Romain Coriat; Alain Dauphin; François Goldwasser; Laura Harcouet; Michel Tod
Saturable absorption of sorafenib in patients with solid tumors: a population model.
Investigational new drugs 2012;30(5):1991-2000.
2012: Olivier Mir; Stanislas Ropert; Julie Giroux; François Goldwasser; Pascaline Boudou-Rouquette; Anatole Cessot; Romain Coriat; Jean-Philippe Durand; Raphaël Gaillard
Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(9):2235-9.
2012: Marie Dior; François Goldwasser; Olivier Mir; Géraldine Perkins; Catherine Brezault; Romain Coriat; Marion Dhooge; Stanislas Chaussade
A rare hematological adverse event induced by bevacizumab: severe thrombocytopenia.
The American journal of medicine 2012;125(8):828-30.
2012: Olivier Mir; Géraldine Perkins; Stanislas Ropert; Pascaline Boudou-Rouquette; Catherine Brezault; Stanislas Chaussade; Romain Coriat; Marion Dhooge; Jean-Philippe Durand; François Goldwasser
Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2.
Anti-cancer drugs 2012;23(7):739-44.
2012: Olivier Mir; Frédérique Larousserie; Philippe Anract; Antoine Babinet; Benoit Blanchet; Pascaline Boudou-Rouquette; François Goldwasser
Durable clinical activity of single-agent bevacizumab in a nonagenarian patient with metastatic alveolar soft part sarcoma.
Anti-cancer drugs 2012;23(7):745-8.
2012: N Pécuchet; Michel Tod; M Viguier; C Lebbe; Olivier Mir; M-F Avril; Bertrand Billemont; B Blanchet; R Coriat; N Franck; François Goldwasser
Sorafenib in advanced melanoma: a critical role for pharmacokinetics?
British journal of cancer 2012;107(3):455-61.
2012: Romain Coriat; Jean-Philippe Durand; Priscille Forgeot d'Arc; Jérôme Alexandre; Pascaline Boudou-Rouquette; Idalie Martin; Olivier Mir; Stanislas Ropert; François Goldwasser
Cost effectiveness of integrated medicine in patients with cancer receiving anticancer chemotherapy.
Journal of oncology practice / American Society of Clinical Oncology 2012;8(4):205-10.
2012: Olivier Mir; Stanislas Ropert; Jérôme Alexandre; Pascaline Boudou-Rouquette; Pierre-Régis Burgel; Jeanne Chapron; Romain Coriat; Jean-Philippe Durand; Daniel Dusser; Laure Gibault; Julie Giroux; François Goldwasser
Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2012;77(1):104-9.
2012: Jean-Philippe Durand; Anatole Cessot; Romain Coriat; Olivier Mir; Sylvain Pourchet; François Goldwasser
Validation of the Cochin Risk Index Score (CRIS) for life expectancy prediction in terminally ill cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(4):857-64.
2012: Olivier Mir; Stanislas Ropert; Bertrand Knebelmann; Bertrand Billemont; Benoit Blanchet; Laure Cabanes; Sandra Camps; Romain Coriat; François Goldwasser
Treatment of bevacizumab-induced hypertension by amlodipine.
Investigational new drugs 2012;30(2):702-7.
2012: Olivier Mir; Frédérique Larousserie; Philippe Anract; Antoine Babinet; P Boudou-Rouquette; Valerie Dumaine; François Goldwasser
Objective response to sorafenib in advanced clear-cell sarcoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(3):807-9.
2012: Pascaline Boudou-Rouquette; Laure Cabanes; Romain Coriat; Nathalie Franck; Bertrand Billemont; Benoit Blanchet; Olivier Mir; Stanislas Ropert; Michel Tod; François Goldwasser
Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis.
The oncologist 2012;17(9):1204-12.
2012: Olivier Mir; Stanislas Pol; Stanislas Ropert; Michel Vidal; Benoit Blanchet; Pascaline Boudou-Rouquette; Stanislas Chaussade; Romain Coriat; Jean-Philippe Durand; Judith Michels; François Goldwasser
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma.
PloS one 2012;7(5):e37563.
2011: Camille Tlemsani; Pascaline Boudou-Rouquette; Romain Coriat; Olivier Huillard; Karin Maley; Olivier Mir; Stanislas Ropert; François Goldwasser
Posterior reversible encephalopathy syndrome induced by anti-VEGF agents.
Targeted oncology 2011;6(4):253-8.
2011: Charline Gomo; Olivier Mir; Stanislas Ropert; Michel Tod; Romain Coriat; Alain Dauphin; Lionel Faivre; François Goldwasser; Bertrand Billemont; Benoit Blanchet
Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinoma.
Investigational new drugs 2011;29(6):1511-4.
2011: Stanislas Ropert; Olivier Vignaux; Olivier Mir; François Goldwasser
VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruption.
Investigational new drugs 2011;29(6):1497-9.
2011: Romain Coriat; Pierre Loulergue; Olivier Mir; Stanislas Ropert; Bertrand Billemont; François Goldwasser
Reactivation of tuberculosis during temsirolimus therapy.
Investigational new drugs 2011;29(6):1494-6.
2011: G Bousquet; H de Mont-Serrat; Sandrine Faivre; François Goldwasser; R Kaiser; C Le Tourneau; J L Misset; Jérôme Alexandre; Eric Raymond
Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients.
British journal of cancer 2011;105(11):1640-5.
2011: Romain Coriat; François Goldwasser; Olivier Mir; Stanislas Pol; Stanislas Chaussade
Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-placenta growth factor inhibitor or multikinase inhibitor sorafenib?
Hepatology (Baltimore, Md.) 2011;54(5):1890-1; author reply 1891.
2011: Romain Coriat; Bertrand Billemont; Benoit Blanchet; Stanislas Chaussade; Pierre-Philippe Massault; Olivier Mir; Stanislas Ropert; Olivier Vignaux; François Goldwasser
Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib.
Investigational new drugs 2011;29(5):1090-3.
2011: Audrey Thomas-Schoemann; Bernard Weill; Frédéric Batteux; Elisabeth Bermudez; Christiane Chéreau; Alain Dauphin; François Goldwasser; François LEMARE; Céline Mongaret; Carole Nicco; Jérôme Alexandre
Bystander effect of vinorelbine alters antitumor immune response.
International journal of cancer. Journal international du cancer 2011;129(6):1511-8.
2011: Olivier Mir; Romain Coriat; Thomas Gregory; Stanislas Ropert; Bertrand Billemont; François Goldwasser
Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agents.
Investigational new drugs 2011;29(4):716-8.
2011: Romain Coriat; Catherine Brezault; Stanislas Chaussade; Sarah Leblanc; Olivier Mir; Stanislas Ropert; François Goldwasser
Feasibility of anti-VEGF agent bevacizumab in patients with Crohn's disease.
Inflammatory bowel diseases 2011;17(7):1632.
2011: Anatole Cessot; Romain Coriat; Claude Beauvillain de Montreuil; Jean-Philippe Durand; François Goldwasser; Xavier Hebuterne; Etienne Lemarie; Christine Mateus; Mauricette Michallet; Olivier Mir; Wulfran Cacheux
Defining the clinical condition of cancer patients: it is time to switch from performance status to nutritional status.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(7):869-70.
2011: Pierre Loulergue; Jérôme Alexandre; I Iurisci; Sophie Grabar; J Medioni; Stanislas Ropert; Véronique Dieras; F Le Chevalier; Stéphane Oudard; François Goldwasser; Pierre Lebon; O Launay
Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study.
British journal of cancer 2011;104(11):1670-4.
2011: Olivier Mir; Stanislas Ropert; Jean-Marc Treluyer; Bertrand Knebelmann; Jérôme Alexandre; Bertrand Billemont; Laure Cabanes; Romain Coriat; Jean-Philippe Durand; François Goldwasser
An observational study of bevacizumab-induced hypertension as a clinical biomarker of antitumor activity.
The oncologist 2011;16(9):1325-32.
2010: Nathalie Franck; Stéphane Barete; Philippe Moguelet; Benoît Blanchet; Agnès Carlotti; Stanislas Ropert; Marie Françoise Avril; Camille Francès; Bertrand Billemont; François Goldwasser
Spiny follicular hyperkeratosis eruption: a new cutaneous adverse effect of sorafenib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(31):e640-2.
2010: Olivier Mir; Stanislas Ropert; Antoine Babinet; Jérôme Alexandre; Frédérique Larousserie; Jean-Philippe Durand; Eric Enkaoua; Philippe Anract; François Goldwasser
Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
Cancer chemotherapy and pharmacology 2010;66(6):1059-63.
2010: Benoit Blanchet; Bertrand Billemont; Stéphane Barete; Hélène Garrigue; Laure Cabanes; Romain Coriat; Camille Francès; Bertrand Knebelmann; François Goldwasser
Toxicity of sorafenib: clinical and molecular aspects.
Expert opinion on drug safety 2010;9(2):275-87.
2010: Pierre-Alexandre Just; Frédérique Tissier; Stéphane Silvera; Bertrand Dousset; Stelly Ballet; Olivier Delattre; Marie-Cécile Vacher-Lavenu; François Goldwasser; Xavier Bertagna; Gonzague De Pinieux
Unexpected diagnosis for an adrenal tumor: synovial sarcoma.
Annals of diagnostic pathology 2010;14(1):56-9.
2010: Romain Coriat; Olivier Mir; Sandra Camps; Stanislas Ropert; Bertrand Billemont; Mahaut Leconte; Frédérique Larousserie; Philippe Anract; Jérôme Alexandre; François Goldwasser
Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.
Cancer chemotherapy and pharmacology 2010;65(3):491-5.
2010: François Goldwasser; Olivier Mir; Stanislas Ropert
[Chemotherapy in unfit bladder cancer patients].
Bulletin du cancer 2010;97 Suppl Cancer de la vessie():35-41.
2009: Olivier Mir; Jérôme Alexandre; Stanislas Ropert; Vincent Montheil; Idalie Martin; Jean-Philippe Durand; François Goldwasser
Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience.
Anti-cancer drugs 2009;20(2):105-8.
2008: Olivier Mir; Paul Berveiller; Stanislas Ropert; François Goffinet; François Goldwasser
Use of platinum derivatives during pregnancy.
Cancer 2008;113(11):3069-74.
2008: Olivier Mir; Paul Berveiller; Stanislas Ropert; F Goffinet; Gérard Pons; Jean-Marc Treluyer; François Goldwasser
Emerging therapeutic options for breast cancer chemotherapy during pregnancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):607-13.
2008: Wulfran Cacheux; Bernard Gourmel; Jérôme Alexandre; Nathalie Germann; Florence Rabillon; Bertrand Duffau; François Goldwasser
An original administration of ifosfamide given once every other week: a clinical and pharmacological study.
Anti-cancer drugs 2008;19(3):295-302.
2007: Stéphane Oudard; Eugeniu Banu; Florian Scotte; Adela Banu; Jacques Medioni; Philippe Beuzeboc; F Joly; J-M Ferrero; François Goldwasser; Jean-Marie Andrieu
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1828-33.
2007: Jean-Yves Blay; serge koscielny; Jean Trédaniel; Bernard Asselain; François Goldwasser; Jean-Louis Misset; Cécile de Labareyre; Charles Hagège; Hervé Bismut; Michel Marty
Rationale and delineation of a composite index of relative antitumoural efficacy (In-RATE).
Critical reviews in oncology/hematology 2007;64(2):106-14.
2007: Jérôme Alexandre; Carmen Kahatt; Frédérique Bertheault-Cvitkovic; Sandrine Faivre; Stephen Shibata; Werner Hilgers; François Goldwasser; François Lokiec; Eric Raymond; Garry Weems; Ajit Shah; John R MacDonald; Esteban Cvitkovic
A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors.
Investigational new drugs 2007;25(5):453-62.
2007: Olivier Mir; Laurence Albiges; Sylviane Arkwright; Denis Duboc; Pierre-Philippe Massault; Florence Tenenbaum; Emmanuel Touzé; Philippe Menasché; Marie-Cécile Vacher-Lavenu; François Goldwasser; Jérôme Alexandre
Primitive neuroectodermal tumor of the myometrium with cardio-vascular symptoms.
Gynecologic oncology 2007;106(3):622-5.
2007: Olivier Mir; Stanislas Ropert; Jérôme Alexandre; François Goldwasser; Jean-Marc Treluyer
CYP3A4/5 and pharmacogenetics in patients with sarcoma.
The lancet oncology 2007;8(8):667-8; author reply 668-9.
2007: Jean-Philippe Durand; B Gourmel; Olivier Mir; François Goldwasser
Antiemetic neurokinin-1 antagonist aprepitant and ifosfamide-induced encephalopathy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):808-9.
2007: Valérie Martinez; Olivier Mir; Julien Dômont; Didier Bouscary; François Goldwasser
Mitoxantrone-related acute myeloblastic leukaemia in a patient with metastatic hormone-refractory prostate cancer.
Anti-cancer drugs 2007;18(2):233-5.
2007: Olivier Mir; Luc Mouthon; Jérôme Alexandre; Jean-Michel Mallion; Gilbert Deray; Loïc Guillevin; François Goldwasser
Bevacizumab-induced cardiovascular events: a consequence of cholesterol emboli syndrome?
Journal of the National Cancer Institute 2007;99(1):85-6.
2007: Jérôme Alexandre; Elisabeth Rey; Véronique Girre; Sophie Grabar; Agnès Tran; V Montheil; F Rabillon; Véronique Dieras; Vincent Jullien; P Hérait; Gérard Pons; Jean-Marc Treluyer; François Goldwasser
Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(1):168-72.
2006: Olivier Mir; Jérôme Alexandre; Stanislas Ropert; François Goldwasser
Oxaliplatin in inoperable or metastatic bladder cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1853-4.
2006: Werner Hilgers; Sandrine Faivre; Stéphanie Chieze; Jérôme Alexandre; François Lokiec; François Goldwasser; Eric Raymond; Carmen Kahatt; Abdelkrim Taamma; Garry Weems; John R MacDonald; Jean-Louis Misset; Esteban Cvitkovic
A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors.
Investigational new drugs 2006;24(4):311-9.
2006: Jérôme Alexandre; Frédéric Batteux; Carole Nicco; Christiane Chéreau; Alexis Laurent; Loïc Guillevin; Bernard Weill; François Goldwasser
Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo.
International journal of cancer. Journal international du cancer 2006;119(1):41-8.
2006: Agnès Tran; Vincent Jullien; Jérôme Alexandre; Elisabeth Rey; F Rabillon; Véronique Girre; Véronique Dieras; Gérard Pons; François Goldwasser; Jean-Marc Tréluyer
Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms.
Clinical pharmacology and therapeutics 2006;79(6):570-80.
2006: Nicolas Chopin; Jérôme Alexandre; Charles Chapron; Laurence Moachon; François Goldwasser
Is thrombotic microangiopathy associated with antitumoral activity?
Gynecologic oncology 2006;101(3):549-50.
2006: Jérôme Alexandre; Carole Nicco; Christiane Chéreau; Alexis Laurent; Bernard Weill; François Goldwasser; Frédéric Batteux
Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.
Journal of the National Cancer Institute 2006;98(4):236-44.
2005: Delphine Amsellem-Ouazana; François Goldwasser; Ivan Bieche; Rosette Lidereau; Marc Zerbib
[Anti-ErbB targeted therapy and urothelial tumors].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2005;15(6 Suppl 1):1229-35.
2005: Olivier Mir; Jérôme Alexandre; Stanislas Ropert; Delphine Amsellem-Ouazana; Thierry Flam; Philippe Beuzeboc; Marc Zerbib; Bernard Debré; Loïc Guillevin; François Goldwasser
Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities.
Anti-cancer drugs 2005;16(9):1017-21.
2005: Jean Trédaniel; Jean-Yves Blay; François Goldwasser; Bernard Asselain; serge koscielny; Cécile de Labareyre; Nives Balogh; Hervé Bismut; Jean-Louis Misset; Michel Marty
Decision making process in oncology practice: is the information available and what should it consist of?
Critical reviews in oncology/hematology 2005;54(3):165-70.
2005: Jean-Philippe Durand; Jérôme Alexandre; Loic Guillevin; François Goldwasser
Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.
Anti-cancer drugs 2005;16(5):587-91.
2005: Alexis Laurent; Carole Nicco; Christiane Chéreau; Claire Goulvestre; Jérôme Alexandre; Arnaud Alves; Eva Lévy; François Goldwasser; Yves Panis; Olivier Soubrane; Bernard Weill; Frédéric Batteux
Controlling tumor growth by modulating endogenous production of reactive oxygen species.
Cancer research 2005;65(3):948-56.
2004: François Goldwasser
[Phase I clinical trials in oncology: ethical issues].
Thérapie 2004;59(4):431-3.
2004: Jérôme Alexandre; Eric Raymond; Mahmoud Ould Kaci; Etienne Brain; François Lokiec; Carmen Kahatt; Sandrine Faivre; Alejandro Yovine; François Goldwasser; Sheri L Smith; John R MacDonald; Jean-Louis Misset; Esteban Cvitkovic
Phase I and pharmacokinetic study of irofulven administered weekly or biweekly in advanced solid tumor patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3377-85.
2004: N Germann; F Goffinet; François Goldwasser
Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(1):146-50.
2003: Jean-Philippe Durand; Catherine Brezault; François Goldwasser
Protection against oxaliplatin acute neurosensory toxicity by venlafaxine.
Anti-cancer drugs 2003;14(6):423-5.
2003: Jean-Philippe Durand; François Goldwasser
[New challenges in medical oncology. From medical oncology to oncological medicine].
Annales de médecine interne 2003;154(3):131-2.
2003: Jérôme Alexandre; Marine Gross-Goupil; B Falissard; M-L Nguyen; Jean-Marie Gornet; Jean-Louis Misset; François Goldwasser
Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(1):36-41.
2002: Marine Gross-Goupil; François Lokiec; G Lopez; Jean-Marie Tigaud; A Hasbini; Didier Romain; Jean-Louis Misset; François Goldwasser
Topotecan preceded by oxaliplatin using a 3 week schedule: a phase I study in advanced cancer patients.
European journal of cancer (Oxford, England : 1990) 2002;38(14):1888-98.
2002: Jean-Philippe Durand; François Goldwasser
Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine.
Anti-cancer drugs 2002;13(7):777-80.
2002: Jean-Marie Gornet; Eric Savier; François Lokiec; Esteban Cvitkovic; Jean-Louis Misset; François Goldwasser
Exacerbation of oxaliplatin neurosensory toxicity following surgery.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1315-8.
2002: N Germann; Marine Gross-Goupil; E Wasserman; Jean-François Emile; Jean-Louis Misset; M Reynes; François Goldwasser
The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):632-6.
2002: Jérôme Alexandre; Jean-Marie Tigaud; Marine Gross-Goupil; Jean-Marie Gornet; Didier Romain; Daniel Azoulay; Jean-Louis Misset; François Goldwasser
Combination of topotecan and oxaliplatin in inoperable hepatocellular cancer patients.
American journal of clinical oncology 2002;25(2):198-203.
2001: Jean-Marie Gornet; François Lokiec; J C Duclos-Vallee; Daniel Azoulay; François Goldwasser
Severe CPT-11-induced diarrhea in presence of FK-506 following liver transplantation for hepatocellular carcinoma.
Anticancer research 2001;21(6A):4203-6.
2001: Jean-François Emile; D Azoulay; Jean-Marie Gornet; LOPES GILBERTO; Valérie Delvart; D Samuel; Michel Reynès; Henri Bismuth; François Goldwasser
Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(7):1005-10.
2001: Francis Lévi; Sylvie Giacchetti; R Zidani; C Brezault-Bonnet; Jean-Marie Tigaud; François Goldwasser; Jean-Louis Misset
Chronotherapy of colorectal cancer metastases.
Hepato-gastroenterology 2001;48(38):320-2.
2001: Suzette Delaloge; Alejandro Yovine; Abdelkrim Taamma; M Riofrio; Etienne Brain; Eric Raymond; Paul-Henri Cottu; François Goldwasser; José Jimeno; Jean-Louis Misset; Michel Marty; Esteban Cvitkovic
Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(5):1248-55.
2000: François Goldwasser; Marine Gross-Goupil; Jean-Marie Tigaud; Mario Di Palma; J Marceau-Suissa; E Wasserman; Alejandro Yovine; Jean-Louis Misset; Esteban Cvitkovic
Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(11):1463-70.
2000: Jean-Marie Gornet; Daniel Azoulay; J C Duclos-Vallée; François Goldwasser
Complete remission of unresectable hepatocellular carcinoma on healthy liver by the combination of aggressive surgery and high-dose-intensity chemotherapy by CPT-11.
Anti-cancer drugs 2000;11(8):649-52.
2000: Jean-Marie Gornet; Daniel Azoulay; F Lévi; Alejandro Yovine; Jean-Louis Misset; François Goldwasser
Dramatic tumor response of bulky liver metastases following treatment with CPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient.
Anti-cancer drugs 2000;11(4):263-8.
1999: E Wasserman; Caroline Cuvier; François Lokiec; François Goldwasser; S Kalla; Dominique Méry-Mignard; M Ouldkaci; A Besmaine; G Dupont-André; Mondher Mahjoubi; Michel Marty; Jean-Louis Misset; Esteban Cvitkovic
Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1751-9.
1999: François Goldwasser; X Buthaud; M Gross; P Bleuzen; Esteban Cvitkovic; A Voinea; C Jasmin; Didier Romain; Jean-Louis Misset
Decreased topotecan platelet toxicity with successive topotecan treatment cycles in advanced ovarian cancer patients.
Anti-cancer drugs 1999;10(3):263-5.
1998: Esteban Cvitkovic; Michel Marty; E Wasserman; Caroline Cuvier; François Goldwasser; Jean-Louis Misset
Re: Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin.
Journal of the National Cancer Institute 1998;90(13):1016-7.
1997: E Wasserman; Anne Myara; François Lokiec; François Goldwasser; François Trivin; Mondher Mahjoubi; Jean-Louis Misset; Esteban Cvitkovic
Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(10):1049-51.
1994: E C Brain; E Raymond; François Goldwasser; Jean-Marc Extra; Michel Marty
[Adamantinoma of the proximal end of the tibia. A case].
Presse médicale (Paris, France : 1983) 1994;23(33):1522-6.
1994: E Raymond; S Walter; François Goldwasser; Marc Espie; Caroline Cuvier; Jean-Marc Extra; Michel Marty
[Metastatic eye neoplasms. Review of the literature apropos of 4 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1994;15(5):318-24.